PMID: 9540249Apr 16, 1998Paper

What internists should know about amiodarone

Cleveland Clinic Journal of Medicine
M T Murphy, B L Wilkoff

Abstract

Amiodarone is a potent and versatile antiarrhythmic. Despite side effects involving the lungs, heart, thyroid, and other organs, it is effective in the treatment of refractory atrial and ventricular arrhythmias and it has unique safety in patients with coronary disease and left ventricular dysfunction. This review discusses the evolving indications for amiodarone and management of toxicities and drug interactions.

Citations

Feb 21, 2002·Critical Care Nursing Quarterly·J M WootenJ Reyes
Jun 26, 2003·Retina·Saad ShaikhMichael F Marmor
Aug 28, 2010·Pharmacotherapy·Daniel E Hilleman, Aryan N Mooss

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

QJM : Monthly Journal of the Association of Physicians
F L Li-Saw-Hee, G Y Lip
The British Journal of Ophthalmology
D V IngramD A Chamberlain
The New England Journal of Medicine
D M Roden, R L Woosley
The New England Journal of Medicine
D M Roden
© 2022 Meta ULC. All rights reserved